Literature DB >> 17428667

Synthesis of andrographolide derivatives: a new family of alpha-glucosidase inhibitors.

Hai-Wei Xu1, Gui-Fu Dai, Gai-Zhi Liu, Jun-Feng Wang, Hong-Min Liu.   

Abstract

Andrographolide (1), the cytotoxic agent of the plant Andrographis paniculata, was subjected to semi-synthetic studies leading to a series of new derivatives, a novel family of glucosidase inhibitors. Nicotination of 3,19-hydroxyls in 15-alkylidene andrographolide derivatives (9) was favorable to alpha-glucosidase inhibition activity. Among them, 15-p-chlorobenzylidene-14-deoxy-11,12-didehydro-3,19-dinicotinateandrographolide (11c) was a very potent inhibitor against alpha-glucosidase with an IC50 value of 6 microM. However, all compounds concerned for beta-glucosidase showed no inhibition. All compounds synthesized were characterized by the analysis of NMR, IR, HRMS spectra and the stereochemistry of 2 was confirmed by X-ray analysis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17428667     DOI: 10.1016/j.bmc.2007.03.063

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  10 in total

Review 1.  Nain-e Havandi Andrographis paniculata present yesterday, absent today: a plenary review on underutilized herb of Iran's pharmaceutical plants.

Authors:  Alireza Valdiani; Mihdzar Abdul Kadir; Soon Guan Tan; Daryush Talei; Mohd Puad Abdullah; Sonia Nikzad
Journal:  Mol Biol Rep       Date:  2011-12-24       Impact factor: 2.316

2.  Anti-cancer activity of heteroaromatic acetals of andrographolide and its isomers.

Authors:  Nitesh Tamang; Christopher Andrews; Sai Kiran Mavileti; Srinivas Nanduri; Nageswara Rao Golakoti; Balasubramanyam Karanam
Journal:  New J Chem       Date:  2022-04-22       Impact factor: 3.925

3.  QSAR Studies on andrographolide derivatives as α-glucosidase inhibitors.

Authors:  Jun Xu; Sichao Huang; Haibin Luo; Guoji Li; Jiaolin Bao; Shaohui Cai; Yuqiang Wang
Journal:  Int J Mol Sci       Date:  2010-03-02       Impact factor: 5.923

4.  An in vitro study of anti-inflammatory activity of standardised Andrographis paniculata extracts and pure andrographolide.

Authors:  Mitchell Low; Cheang S Khoo; Gerald Münch; Suresh Govindaraghavan; Nikolaus J Sucher
Journal:  BMC Complement Altern Med       Date:  2015-02-07       Impact factor: 3.659

5.  Andrographolide sodium bisulphite-induced inactivation of urease: inhibitory potency, kinetics and mechanism.

Authors:  Zhi-Zhun Mo; Xiu-Fen Wang; Xie Zhang; Ji-Yan Su; Hai-Ming Chen; Yu-Hong Liu; Zhen-Biao Zhang; Jian-Hui Xie; Zi-Ren Su
Journal:  BMC Complement Altern Med       Date:  2015-07-16       Impact factor: 3.659

Review 6.  In search of therapeutic candidates for HIV/AIDS: rational approaches, design strategies, structure-activity relationship and mechanistic insights.

Authors:  Dinesh Kumar; Pooja Sharma; Ramandeep Kaur; Maloba M M Lobe; Girish K Gupta; Fidele Ntie-Kang
Journal:  RSC Adv       Date:  2021-05-18       Impact factor: 4.036

7.  Tricyclic Aza-Andrographolide Derivatives from Late-Stage Hydroamination and Their Anti-human Coronavirus (Anti-HCoV) Activity.

Authors:  Chao Che; Ding Jiang; Jiayin Zhang; Qi Xing; Ting Li; Yi Zhao; Liangyu Guan; Huangcan Chen; Dehu Xiang; Man Di; Zhendong Zhu
Journal:  ACS Omega       Date:  2022-07-07

8.  Role of semi-purified andrographolide from Andrographis paniculata extract as nano-phytovesicular carrier for enhancing oral absorption and hypoglycemic activity.

Authors:  Vinod Kumar Verma; Md Kamaruz Zaman; Shekhar Verma; Santosh Kumar Verma; Khomendra Kumar Sarwa
Journal:  Chin Herb Med       Date:  2019-12-25

9.  Andrographolide: a new plant-derived antineoplastic entity on horizon.

Authors:  Astha Varma; Harish Padh; Neeta Shrivastava
Journal:  Evid Based Complement Alternat Med       Date:  2011-02-10       Impact factor: 2.629

10.  Hypoglycemic and beta cell protective effects of andrographolide analogue for diabetes treatment.

Authors:  Zaijun Zhang; Jie Jiang; Pei Yu; Xiangping Zeng; James W Larrick; Yuqiang Wang
Journal:  J Transl Med       Date:  2009-07-16       Impact factor: 5.531

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.